drugset / Trial / NCT05475873
Ondansetron for Postspinal Anesthesia Hypotension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the effectiveness of ondansetron for postspinal anesthesia hypotension in patients undergoing cesarean section.
Timeline
- Start
- 2023-06-18
- Primary completion
- 2023-10-27
- Completion
- 2023-10-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 4 mg | Intravenous |
| Subject | Ondansetron | Other / unclassified | 8 mg | Intravenous |
Indications
No indication recorded.